CT-524 Orca-T, A Precision Engineered Allograft, Results in High GVHD-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies

Clinical Lymphoma, Myeloma and Leukemia - Tập 22 - Trang S447 - 2022
Everett Meyer1, Anna Pavlova2, Arpita Gandhi3, Rasmus Hoeg4, Caspian Oliai5, Rohtesh Mehta6, Samer Srour6, Joseph McGuirk7, Edmund Waller8, Nathaniel Fernhoff9, M. Scott Killian9, James Mcclellan9, Amy Putnam10, Bronwen Shaw11, Mehrdad Abedi4, Robert Negrin2
1Stanford University, Palo Alto, USA
2Stanford University Palo Alto, USA
3Oregon Health & Science University, Portland, USA
4UC Davis, Sacramento, USA
5UCLA, Los Angeles, USA
6The University of Texas MD, Anderson Cancer Center, Houston, USA
7University of Kansas, Kansas City, USA
8Emory University, Atlanta, USA
9Orca Bio, Menlo Park, USA
10Orca Bio, Sacramento, USA
11Medical College of Wisconsin, Milwaukee USA

Thông tin
Thông tin xuất bản

Clinical Lymphoma, Myeloma and Leukemia

Tập 22

S447

Thông tin tác giả